Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 57.90
+0.90 (1.58%)
At close: Jul 9, 2026
Bionime Market Cap
Bionime has a market cap or net worth of 4.41 billion as of July 9, 2026. Its market cap has decreased by -2.55% in one year.
Market Cap
4.41B
Enterprise Value
6.52B
Revenue
1.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
57.90
Market Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 4.41B, an increase of 113.49%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 4.41B | 10.04% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioteque | 8.11B |
| Medeon Biodesign | 7.05B |
| Pacific Hospital Supply | 5.92B |
| Formosa Optical Technology | 5.41B |
| St.Shine Optical | 4.98B |
| SciVision Biotech | 4.07B |
| Maxigen Biotech | 3.65B |
| ICARES Medicus | 3.50B |